HSCS Heart Test Labs Expected net earnings per share growth this year
High barriers to entry are ensured by AI-powered ECG analysis patents and strict FDA regulations. The relative change in EPS over the year demonstrates profit dynamics, with 25.90 representing the latest level value. Heart Test Laboratories (HSCS) generates revenue through the sale of diagnostic equipment and cloud software. The stability of the business is guaranteed by the humanitarian status of medicine and a strategic focus on the US market.
Analytical breakdowns and data insights for company Heart Test Laboratories (HSCS)
- current quotes and average value forecast:
- market capitalization data:
- shareholders' equity book value data:
- debt burden and liquidity indicators:
Total Debt to Capital Heart Test Laboratories|HSCS - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital heartsciences.com|HSCS - Company Total Debt|Debt to Book Capital Heart Test Labs|HSCS - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings HeartSciences|Intermediate Liquidity Ratio heartsciences.com
- net income and valuation multiples indicators:
HSCS - Net Profit|Expected Net Profit Heart Test Laboratories|HSCS - Price to Earnings Ratio|Market Cap to Projected Earnings Heart Test Labs|HSCS - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Heart Test Labs|HSCS - Operating profit before deduction of amortization|Earnings per share for the trailing year HeartSciences|HSCS - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months heartsciences.com|HSCS - Earnings growth in current year|Earnings growth forecast for next year Heart Test Laboratories
Summary company analysis:Heart Test Laboratories, Inc. - HSCS
Market expectations for Heart Test Laboratories (HSCS) depend on the company's ability to monetize its technological edge. This annual earnings per share volatility metric measures the growth rate of net income per share relative to the previous year, revealing the actual efficiency of capitalization. For Heart Test Laboratories, this price action reflects the transition from the clinical validation stage of its AI platform to actual revenue growth.
Key competitors
A - Expected net earnings per share growth this year|Earnings per share growth in current year Quest|Illumina Platform (ILMN) - Expected net earnings per share growth this year|Earnings growth in current year EXAS|RVTY (revvity.com) - Earnings per share increase in current year|Earnings growth in current year BIO (Bio-Rad)|Anbio Biotechnology Ltd (NNNN) - Earnings per share growth rate in current year|Sterigenics - Earnings growth in current year|QDEL - Earnings growth in current year|OPKO Health, Inc. (OPK) - Earnings per share growth in current year|CareDx - Earnings per share increase in current year|Net earnings per share growth this year MRVI|FLGT (Fulgent Genetics Inc) - Net earnings per one share growth for the current year|Net earnings per share growth this year LAB (Fluidigm)|CTKB (Cytek Corp) - Earnings per share increase in current year|OraSure Technologies - Net earnings per share growth this year|Net earnings per one share growth for the current year XGN (Exagen Inc)|MDxHealth - Earnings growth in current year|Earnings per share growth rate in current year Lucid Diagnostics, Inc.|prenetics.com (PRE) - Earnings per share growth in current year|IMDX - Expected net earnings per share growth this year|Net earnings per share growth this year TRIB|PRPH (prophaselabs.com) - Net earnings per one share growth for the current year|Net earnings per share growth this year AIMD (Ainos)|CODX (Co-Diagnostics Inc) - Earnings per share increase in current year|Earnings per share growth in current year Biomerica, Inc BMRA|Cardio Diagnostics Holdings Inc. - Earnings per share growth in current year|Onconetix, Inc. - Earnings growth in current year|VRAX - Earnings growth in current year|BJDX: Earnings growth in current year|AWH (Aspira Women's Health, Inc.) - Earnings per share growth in current year|Earnings per share growth in current year Accelerate Diagnostics, Inc|Earnings per share growth rate in current year CENTOGENE N.V. CNTG|Earnings per share growth in current year Enzo Biochem, Inc. (ENZ)|FRES (fresh2.co) - Earnings per share increase in current year|Earnings growth in current year GENE (Genetic Technologies Limited)|Earnings growth in current year 23andMe Holding Co ME|PMD: Net earnings per share growth this year
